Introduction
TABLE OF CONTENTS
6 TO 50
383 TO 406
A 1% decrease in the terminal growth rate on all the Group’s Cash Generating Units would lead to an impairment loss risk of around €14.8 million.
The terminal growth rate is consistent with market data, i.e. 2.5% for Europe and 3.0% for the rest of the world.
A 1-point decrease in the margin rate over the business plan period on all the Group’s Cash Generating Units would lead to an impairment loss risk of around €17.2 million.
L'Oréal used two opposing scenarios to measure the risks and opportunities related to climate change that could impact the Group's activities in the medium and long term. The methodology used is in line with the practices of the TCFD (Task Force on Climate-related Financial Disclosures) and the TNFD (Taskforce on Nature-related Financial Disclosures). The scenarios used are:
The net carrying amount of goodwill and brands with indefinite useful life breaks down as follows for the largest Cash Generating Units:
This chart shows the net carrying amount of goodwill and brands with indefinite useful lives, broken down as follows for the most significant Cash-Generating Units (CGUs).
2024:
Retail Skincare (Luxe): approximately 2,500
Fragrances: approximately 1,750
L'Oréal Paris: approximately 1,250
Mass Market Makeup: approximately 1,150
Luxury Makeup: approximately 1,050
SkinCeuticals / Skinbetter Science: approximately 950
Lancôme: approximately 800
CeraVe: approximately 750
Redken / PureOlogy: approximately 750
Matrix: approximately 700
Luxury Skincare: approximately 700
YSL Beauté: approximately 580
Stylenanda: approximately 550
NYX Professional Makeup: approximately 500
Garnier: approximately 500
L'Oréal Professionnel / Kérastase: approximately 500
Vichy: approximately 250
2023:
Retail Skincare (Luxe): approximately 2,500
Fragrances: approximately 1,750
L'Oréal Paris: approximately 1,230
Mass Market Makeup: approximately 1,120
Luxury Makeup: approximately 1,050
SkinCeuticals / Skinbetter Science: approximately 960
Lancôme: approximately 800
CeraVe: approximately 750
Redken / PureOlogy: approximately 750
Matrix: approximately 700
Luxury Skincare: approximately 700
YSL Beauté: approximately 580
Stylenanda: approximately 550
NYX Professional Makeup: approximately 500
Garnier: approximately 500
L'Oréal Professionnel / Kérastase: approximately 500
Vichy: approximately 250
2022:
Retail Skincare (Luxe): approximately 55
Fragrances: approximately 1,750
L'Oréal Paris: approximately 1,200
Mass Market Makeup: approximately 1,100
Luxury Makeup: approximately 1,050
SkinCeuticals / Skinbetter Science: approximately 1,000
Lancôme: approximately 800
CeraVe: approximately 750
Redken / PureOlogy: approximately 750
Matrix: approximately 700
Luxury Skincare: approximately 700
YSL Beauté: approximately 580
Stylenanda: approximately 550
Garnier: approximately 500
NYX Professional Makeup: approximately 500
L'Oréal Professionnel / Kérastase: approximately 500
Vichy: approximately 250
€ millions | 31.12.2024 | 31.12.2023 | 31.12.2022 |
---|---|---|---|
Investments accounted for under the equity method | Investments accounted for under the equity method 31.12.2024
|
||
Amouage(1) | Amouage (1)31.12.2024 102.0 |
Amouage (1)31.12.2023 — |
Amouage (1)31.12.2022 — |
LIPP Distribution | LIPP Distribution 31.12.2024 12.1 |
LIPP Distribution 31.12.2023 12.0 |
LIPP Distribution 31.12.2022 9.9 |
Loshian Co(2) | Loshian Co (2)31.12.2024 — |
Loshian Co (2)31.12.2023 5.8 |
Loshian Co (2)31.12.2022 8.1 |
Salon Interactive | Salon Interactive 31.12.2024 11.9 |
Salon Interactive 31.12.2023 8.8 |
Salon Interactive 31.12.2022 — |
Other | Other 31.12.2024 0.4 |
Other 31.12.2023 0.5 |
Other 31.12.2022 0.5 |
TOTAL | TOTAL 31.12.2024 126.4 |
TOTAL 31.12.2023 27.0 |
TOTAL 31.12.2022 18.4 |